Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Podophyllotoxin derivatives")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3098

  • Page / 124
Export

Selection :

  • and

Etoposide et risque leucémogène = Etoposide leukemogenicityGUENFOUDI-ROULLAUD, M. P; MENAT, C; GIRARD, F et al.Journal de pharmacie clinique (Paris). 1998, Vol 17, Num 2, pp 71-73, issn 0291-1981Article

Etoposide for the treatment of paediatric tumours : What is the best way to give it ?LOWIS, S. P; NEWELL, D. R.European journal of cancer (1990). 1996, Vol 32, Num 13, pp 2291-2297, issn 0959-8049Article

Naphthalene analogues of lignansMADRIGAL, Blanca; PUEBLA, Pilar; PELAEZ, Rafael et al.Journal of organic chemistry. 2003, Vol 68, Num 3, pp 854-864, issn 0022-3263, 11 p.Article

4-aza-2,3-didéhydropodophyllotoxines : nouveaux lignanes à activité antitumorale obtenus par une synthèse en une seule étape = 4-Aza-2,3-didehydropodophyllotoxins: new lignan with antitumor activity obtained from one-step synthesisGIORGI-RENAULT, S.Annales pharmaceutiques françaises. 2005, Vol 63, Num 1, pp 63-68, issn 0003-4509, 6 p.Article

Estimation bayésienne des paramètres pharmacocinétiques de l'étoposide = Bayesian estimation of etoposide pharmacokinetic parametersEVENE, E; CHATELUT, E; TRANCHAND, B et al.Bulletin du cancer. 1997, Vol 84, Num 7, pp 699-703, issn 0007-4551Article

Précision des préparations à base de cytostatiques : étude réalisée sur 3 unités centralisées de reconstitution = Precision of the cytotoxics preparations : study realized on 3 cytotoxics drug preparation unitGIRARD, F; MENAT, C; GUENFOUDI, M.-P et al.Journal de pharmacie clinique (Paris). 1999, Vol 18, Num 1, pp 62-63, issn 0291-1981Conference Paper

Low-dose oral etoposide monotherapy in adult Langerhans cell histiocytosisHELMBOLD, P; HEGEMANN, B; HOLZHAUSEN, H.-J et al.Archives of dermatology (1960). 1998, Vol 134, Num 10, pp 1275-1278, issn 0003-987XArticle

High-performance liquid chromatography of etoposide in plasma and urineHARVEY, V. J; JOEL, S. P; JOHNSTON, A et al.Journal of chromatography. 1985, Vol 339, Num 2, pp 419-423, issn 0021-9673Article

Biosynthesis of Podophyllum lignans. II: Interconversions of aryltetralin lignans in Podophyllum hexandrumJACKSON, D. E; DEWICK, P. M.Phytochemistry. 1984, Vol 23, Num 5, pp 1037-1042, issn 0031-9422Article

Antitumor agents LXII: synthesis and biological evaluation of podophyllotoxin esters and related derivatives = Agents antitumoraux. LXII. Synthèse et évaluation biologique des esters de podophyllotoxine et des dérivés apparentésLEVY, R. K; HALL, I. H; KUO-HSIUNG LEE et al.Journal of pharmaceutical sciences. 1983, Vol 72, Num 10, pp 1158-1161, issn 0022-3549Article

CYTOTOXIC AGENTS OF THUJOPSIS DOLABRATA (L. FIL.) SIEB. ET ZUCC1972; CHEM. PHARM. BULL.; JAP.; DA. 1972; VOL. 20; NO 6; PP. 1150-1155; BIBL. 12REF.Serial Issue

Aryltetralin lignans from Podophyllum hexandrum and Podophyllum peltatumJACKSON, D. E; DEWICK, P. M.Phytochemistry. 1984, Vol 23, Num 5, pp 1147-1152, issn 0031-9422Article

MOLECULAR CROWDING AND REMOTE SUBSTITUENT EFFECTS IN 1-ARYLTETRAHYDRONAPHTALENE DERIVATIVESAYRES DC; CHONG KEE LIM.1973; J. CHEM. SOC., CHEM. COMMUNIC.; G.B.; DA. 1973; NO 14; PP. 487-488; BIBL. 11 REF.Serial Issue

INTERNATIONAL SYMPOSIUM ON THE PODOPHYLLOTOXINS IN CANCER THERAPY, SOUTHAMPTON, ENGLAND, JULY 8-9, 1981CARTER SK ED; MATHE G ED; MCELWAIN T ED et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 7; NO 2-3; 163 P.; BIBL. DISSEM.Conference Paper

PHOTOCHEMICAL REACTIONS. I. A NEW ROUTE TO TETRADEHYDROPODOPHYLLOTOXIN, TAIWANIN E, AND RELATED COMPOUNDSARNOLD BJ; MELLOWS SM; SAMMES PG et al.1973; J. CHEM. SOC., PERKIN TRANS., 1; DA. 1973; NO 12; PP. 1266-1270; BIBL. 23 REF.Serial Issue

Chromosomal aberrations induced by 5-azacytidine combined with VP-16 (etoposide) in CHO-K1 and XRS-5 cell linesGUIMARAES, A. P. A; DIAS, F. L; CARDOSO, R. S et al.Teratogenesis, carcinogenesis, and mutagenesis. 2003, pp 171-186, issn 0270-3211, 16 p., SUP1Article

A randomized trial of treatment for multisystem Langerhans' cell histiocytosisGADNER, Helmut; GROIS, Nicole; PRITCHARD, Jon et al.The Journal of pediatrics. 2001, Vol 138, Num 5, pp 728-734, issn 0022-3476Article

Chromosome aberrations after etoposide containing cisplatin-based chemotherapy for malignant germ-cell tumoursHERNANDEZ, A. M; FOSSA, S. D; BRØGGER, A et al.Annals of oncology. 2000, Vol 11, Num 7, pp 897-898, issn 0923-7534Article

Developmental toxicity of the topoisomerase inhibitor, etoposide, in rabbits after intravenous administrationNAGAO, T; YOSHIMURA, S; SAITO, Y et al.Teratogenesis, carcinogenesis, and mutagenesis. 1999, Vol 19, Num 3, pp 233-241, issn 0270-3211Article

Lignans from the seeds of Hernandia sonoraUDINO, L; ABAUL, J; BOURGEOIS, P et al.Planta medica. 1999, Vol 65, Num 3, pp 279-281, issn 0032-0943Article

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxinsSMITH, M. A; RUBINSTEIN, L; MISER, J et al.Journal of clinical oncology. 1999, Vol 17, Num 2, pp 569-577, issn 0732-183XArticle

The mechanism of photo-ionization of podophyllotoxin and its derivatives : a laser flash photolysis studyWANG, S.-L; YAO, S.-D; WANG MEI et al.Radiation physics and chemistry (1993). 1998, Vol 53, Num 6, pp 623-628, issn 0969-806XArticle

A novel enzymatic dehydrogenation of podophyllotoxin congeners by yeast cellsKAMAL, A; DAMAYANTHI, Y.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 6, pp 657-662, issn 0960-894XArticle

Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposideTOFFOLI, G; SORIO, R; GIGANTE, M et al.British journal of cancer. 1997, Vol 75, Num 5, pp 715-721, issn 0007-0920Article

Phamacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumorsKREIS, W; BUDMAN, D. R; VINCIGUERRA, V et al.Cancer chemotherapy and pharmacology. 1996, Vol 38, Num 4, pp 378-384, issn 0344-5704Article

  • Page / 124